An Open-Label, Single-Dose, Study to Assess the Metabolism and Elimination of Varespladib After Oral Administration of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 19 Dec 2011
At a glance
- Drugs Varespladib (Primary)
- Indications Acute coronary syndromes; Atherosclerosis; Coronary artery disease; Myocardial infarction
- Focus Pharmacokinetics
- 18 Oct 2011 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
- 18 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jun 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.